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ABSTRACT The ability of secretory phospholipase A2 (sPLA2) to hydrolyze cell membranes is highly dependent on the physical
properties of the membrane. The effects of cholesterol on these properties have been characterized in artiﬁcial bilayers and found
to alter sPLA2 activity signiﬁcantly. It is hypothesized that the natural difference in cholesterol content between erythrocytes and
leukocytes is in part responsible for their differing susceptibility to hydrolysis by sPLA2. To test this hypothesis, deﬁned amounts of
cholesterolwere removed fromerythrocytemembranes usingmethyl-b-cyclodextrin. Treatment of cellswithmethyl-b-cyclodextrin
increased the hydrolysis rate and total substrate hydrolyzed by sPLA2. In general, this effect of cholesterol removal was more
pronouncedat higher temperatures.Comparisonof the level ofmembraneorder (assessedwith theﬂuorescent probe laurdan)with
hydrolysis rate revealed that sPLA2 activity was greatly enhanced upon signiﬁcant reductions in lipid order. Additional treatment of
the cellswith calcium ionophore further enhanced the hydrolysis rate and altered the relationshipwithmembraneorder. Thesedata
demonstrated that interactions with sPLA2 observed in artiﬁcial bilayers apply to biological membranes. It is also proposed that the
high level of cholesterol in erythrocyte membranes is a protective mechanism to guard against hydrolytic enzymes.
INTRODUCTION
An important objective of membrane biophysics is to apply
lessons learned with artiﬁcial bilayers to biological mem-
branes. Oftentimes meeting this objective presents a signiﬁ-
cant challenge due to the complexity of biological membranes
compared to the models commonly studied (e.g., Yethiraj and
Weisshaar (1)). One possible candidate formaking signiﬁcant
connections between artiﬁcial and physiological systems is
the enzyme secretory phospholipase A2 (sPLA2). The prom-
inent observation associatedwith this enzyme is its preference
for substrate molecules in an aggregated state (as micelles,
monolayer, or bilayer (reviewed in Gelb et al. (2) and Winget
et al. (3)). Nevertheless, simple formation of a lipid aggregate
is not the sole requirement for efﬁcient catalysis, since the
enzyme discriminates among potential substrates on the basis
of the physical properties of the interface.
Many artiﬁcial membranes resist catalysis by sPLA2,
especially those composed of saturated zwitterionic phos-
pholipids such as phosphatidylcholine (4–8). However, spe-
ciﬁc physical perturbations to the membrane such as increased
local curvature, incorporation of negative charges, or con-
tamination with certain molecules such as fatty acid or
lysophospholipid cause it to become susceptible to hydrolysis
(4,8–14). A prominent feature common among many of these
perturbations is a reduction in favorable interactions among
neighboring phospholipids allowing easier access of sub-
strate into the active site of enzyme adsorbed to the surface of
the membrane (8,14,15). A second factor that inﬂuences the
activity of sPLA2 is the membrane lipid phase expressed at
the moment the perturbant and enzyme are added to the bi-
layer. In general, the enzyme is more active toward lipids in a
liquid disordered phase (4,7,8,14,16,17). Several lines of
evidence suggest that these two factors, the perturbant and
the lipid phase, affect enzyme activity by separate mecha-
nisms (5–8). Notwithstanding, the effectiveness of the per-
turbant may be inﬂuenced by the lipid phase present when the
perturbant is introduced (7,8).
Initial attempts at applying these principles from artiﬁcial
bilayers to biological membranes have been encouraging. In
general, the membranes of healthy cells behave like unper-
turbed phosphatidylcholine bilayers in that they resist catalysis
by the enzyme. Those of traumatized, necrotic, or apoptotic
cells are more susceptible (reviewed in Brueseke and Bell
(18)). Such behavior has been best established in human
erythrocytes and various types of leukocytes (19–23). An
important advantage of erythrocytes is the relative simplicity
of their membrane compared to nucleated cells. Thus, they
have been used as a model for investigations into the mech-
anisms governing the level of membrane hydrolysis by
sPLA2. Cellular trauma is simulated in erythrocytes by using
an ionophore (ionomycin) to load them with calcium. This
treatment produces a signiﬁcant enhancement in the ability of
sPLA2 to hydrolyze membrane phospholipids and appears to
mimic the behavior of the ‘‘perturbants’’ in artiﬁcial mem-
branes (21–24).Moreover, it appears to do so by amechanism
analogous to that identiﬁed in artiﬁcial bilayers: facilitation of
substrate entry into the enzyme active site (23,24).
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Preliminary evidence suggests that the perturbation phe-
nomenon is not the only parallel between biological and ar-
tiﬁcialmembranes.Apparently, the second factor, lipid phase,
is also relevant (22). Lipid phases cannot be deﬁned rigor-
ously for biological membranes, but temperature studies with
erythrocytes suggest that increased lipid disorder induced by
elevated temperature promotes the effectiveness of the per-
turbant (calcium loading) and the overall hydrolytic activity
of sPLA2 (22,23). Nevertheless, these studies were limited by
the range of membrane properties that could be explored by
varying the experimental temperature.
Numerous studies in artiﬁcial bilayers suggest that removal
ofmembrane cholesterolmight be an effectivemeans of better
assessing the relationship between lipid order and sPLA2
activity in erythrocytes. In model membranes, the general
effects of cholesterol on bilayer properties have been well
characterized (25–32). Furthermore, the presence of choles-
terol in the bilayer alters the activity of sPLA2 substantially in
these model systems (33–37). Although the relationships
among cholesterol, membrane order, and sPLA2 activity have
not been studied in biological membranes, a few observations
comparing erythrocytes to lymphocytes suggest that such
investigations could be fruitful and physiologically relevant.
First, the rate of hydrolysis of susceptible leukocytes is much
greater than the rate in susceptible erythrocytes (19,21,23,24).
Second, the cell membrane of erythrocytes contain 50–100%
more cholesterol (38–40) than does that of other cells in-
cluding leukocytes (40–42). Given the sensitivity of sPLA2 to
membrane structure in general and cholesterol concentration
speciﬁcally, it is reasonable to hypothesize that membrane
cholesterol content might account, at least partially, for the
difference in susceptibility of erythrocytes and lymphocytes
to hydrolysis by the enzyme. Encouragement for this hy-
pothesis can be found in a few older observations that phos-
pholipase A2-catalyzed hydrolysis of mycoplasma and human
platelet membranes is enhanced if these cells are deprived of
cholesterol (43,44).
To test that hypothesis and better understand relation-
ships between cell membrane properties and sPLA2 activity,
we treated human erythrocytes with methyl-b-cyclodextrin
(MBCD) to remove deﬁned amounts of cholesterol from the
membrane. Cyclodextrins have been used in pharmacology
research for years to aid in the delivery of lipophilic drugs.
Recently they have become important in membrane studies
mainly because they have been shown to selectively extract
membrane cholesterol in multiple cell types, including eryth-
rocytes (45–48). The cell membrane effects mediated by cy-
clodextrins appear to be limited to their ability to extract lipids
since they neither bind to nor incorporate into the membrane
(46). MBCD acts at the membrane surface extracting choles-
terol into a central, nonpolar cavity of cyclic oligomers of
glucopyranoside (49). In this study, the effect of cholesterol
removal on membrane hydrolysis by sPLA2 with or without
calcium ionophore was assessed at various temperatures. The
hydrolysis results were then compared to corresponding al-




Secretory PLA2 (monomeric aspartate 49 from the venom of Agkistrodon
piscivorus piscivorus) was isolated according to published procedures (50)
and dissolved in 50 mM KCl with 3 mM NaN3 as a preservative. Ionomycin
was acquired from Calbiochem (La Jolla, CA) and dissolved in dime-
thylsulfoxide (DMSO). The probes laurdan (6-dodecanoyl-2-dimethylamino-
napthalene) and acrylodan-labeled fatty acid-binding protein (ADIFAB)
were purchased from Invitrogen (Carlsbad, CA). Laurdan was dissolved in
DMSO and ADIFAB in 50 mMKCl with 3 mMNaN3. MBCDwas obtained
from Sigma-Aldrich (St. Louis, MO) and dissolved in modiﬁed basic salt
solution (MBSS: NaCl¼ 134mM,KCl¼ 6.2mM, CaCl2¼ 1.6mM,MgCl2¼
1.2 mM, Hepes¼ 18.0 mM, and glucose¼ 13.6 mM, pH 7.4, 37C). All other
reagents were purchased from standard sources.
Preparation of erythrocytes
Blood samples were obtained from donors during physical exams at the
Brigham Young University McDonald Health Center. The samples were
fresh or stored up to 2 days at 4C in EDTA vacutainers from which patient
identiﬁcation was removed. Control experiments comparing fresh blood with
stored samples demonstrated that the storage conditions did not inﬂuence the
results (21). Erythrocytes were isolated by centrifugation (plasma and buffy
coat removed), washed, and resuspended in MBSS. This stock suspension
was then diluted to 3% hematocrit.
To deplete membrane cholesterol, 50 ml samples of washed diluted
erythrocytes were suspended in 1 ml MBSS containing 1.0 mMMBCD and
incubated at 37C for 30 min. After washing, cells were resuspended in
MBSS and placed in a quartz cuvette. Control cells were treated identically
with MBSS devoid of MBCD.
The cholesterol content of MBCD-treated erythrocytes was determined
using the Amplex Red Cholesterol Assay Kit from Invitrogen. Cells were
treated with MBSS or MBCD as described above, and isolated by centrifu-
gation. Cholesterol was extracted from the supernatant by adding an equal
volume of chloroform, vortexing, removing the organic layer, and drying
under a nitrogen stream. Cell pellets were lysed by freezing in liquid nitro-
gen. Samples were quickly thawed, and lipids were extracted with chloro-
form and methanol as described (51). The organic layer was dried under
a nitrogen stream. Samples were assayed for cholesterol according to
instructions provided with the kit.
Fluorescence spectroscopy
Steady-state ﬂuorescence (laurdan or ADIFAB)was detected using a photon-
counting spectroﬂuorometer (Fluoromax-3 fromHoriba Jobin Yvon, Edison,
NJ). Sample homogeneity was assured by continuous stirring (magnetic stir
bar), and temperature was maintained using a circulating water bath. Samples
were equilibrated for at least 5 min at the experimental temperature before
data acquisition. Simultaneous assessment of ﬂuorescence intensity at mul-
tiple excitation and emission wavelengths was obtained by rapid sluing of
monochromator mirrors using control software provided with the instrument.
Monochromator bandpass was set at 4 nm.
For experiments designed to assess membrane physical properties,
erythrocyte preparations were suspended in 2 ml of MBSS in a quartz ﬂu-
orometer sample cell to a ﬁnal density of ;3–4 3 106 cells/ml (0.075%
hematocrit). Samples were incubated at least 20 min at 40C to equilibrate
laurdan with cell membranes (ﬁnal concentration ¼ 0.25–2.5 mM, see leg-
ends to ﬁgures) before measuring the emission intensity at 435 and 500 nm
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(excitation, 350 nm). Results were quantiﬁed by calculating the generalized
polarization (GP) from the two emission intensities as described by Parasassi
et al. (52).
The ﬂuorescent fatty acid binding protein ADIFAB (ﬁnal concentration
65 nM) was used to assay the release of free fatty acids from erythrocytes
(excitation, 390 nm; emission, 432 nm and 505 nm) (36,53). Erythrocyte
preparations were suspended as in the laurdan experiments. After initiating
data acquisition, ADIFAB was added at 80 s, followed by ionomycin (300
nM) or equivalent volume of control solvent (DMSO) at 100 s, and sPLA2
(1 mg/ml) at 700 s. In the absence of fatty acid, the acrylodan ﬂuorophore in
ADIFAB occupies the fatty acid binding site on the protein where it is mostly
isolated from water molecules. Free fatty acids released during hydrolysis
bind to ADIFAB displacing the acrylodan group and exposing it to solvent.
The sensitivity of acrylodan to the solvent relaxation effect results in a
proportional decrease in emission at 432 nm concurrent with an increase at
505 nm (36,54). To quantify the results, the GP was calculated from the
intensities at 432 and 505 nm and then ﬁt to a double exponential rate law by
nonlinear regression as described previously (53). The initial rate (evaluated
at the 20 s time point) and total amount of hydrolysis (estimated from the
500 s time point) were calculated directly using the regression parameter
values.
Additional control experiments using MBCD preloaded with cholesterol
were included to test the assumption that the effects ofMBCD are conﬁned to
the removal of cholesterol from themembrane. Preloading was accomplished
by incubating MBCD with erythrocytes at 0.75% hematocrit for 30 min at
37C. Erythrocytes were then removed by centrifugation, and the supernatant
(containing MBCD loaded with cholesterol) was added to an erythrocyte
sample for extraction of cholesterol as described above.
Two-photon excitation scanning microscopy
Two-photon images were collected with an Axiovert 35 inverted microscope
(Zeiss, Thornwood, NY) at the Laboratory for Fluorescence Dynamics
(University of California, Irvine) as described previously (55). Instrument
optics split the emission signal and directed it through interference ﬁlters
(Ealing 490 and Ealing 440) to generate the data required for calculation of
GP. Laser emission was set at 780 or 790 nm. Samples were prepared for
laurdan ﬂuorescence (250 nM laurdan) as described above and incubated in
microscopy dishes thermostated at 37C. Spatial maps of laurdan GP were
created and analyzed with software provided by the laboratory. Histograms
(number of pixels per GP value) and average GP values were obtained for
individual cells and also for the central region (45.96 4.9% of the total cell
area) of those same cells. Histograms for the perimeter of each cell were then
obtained by calculating the difference between the histograms for the whole
cell and central region of the cell. The average GP value for the perimeter of
each cell was calculated using the following equation with the following
subscript designations: w ¼ whole cell, c ¼ central region, p ¼ perimeter.




Fig. 1 shows time courses of membrane hydrolysis by sPLA2
at 37C. In panel A, cells were treated with or without 1 mM
MBCD, washed, and then mixed with sPLA2. This treatment
procedure removed 73.4% of membrane cholesterol, thus re-
ducing the cholesterol content from;47% ofmembrane lipids
to ;19%. Untreated erythrocytes were relatively resistant to
hydrolysis by sPLA2, whereas MBCD-treated erythrocytes
were more susceptible to hydrolysis by the enzyme. Panel B
contains analogous data for cells also treated for 10 min with
ionomycin. Ionomycin increased the initial rate of hydrolysis
of both normal and MBCD-treated cells particularly at the
shorter time intervals. The same set of experiments was re-
peated at various temperatures and the initial hydrolysis rate
calculated (Fig. 2 A). As reported previously (22), the initial
hydrolysis rate did not vary signiﬁcantly with temperature in
control samples (p ¼ 0.54). Extraction of cholesterol by
MBCD, however, produced an enhanced hydrolysis rate, es-
pecially at the upper end of the temperature range. Conse-
quently, a signiﬁcant trend with temperature was observed for
MBCD-treated samples (p ¼ 0.004 by linear regression).
Addition of ionomycin (Fig. 2 B) to untreated cells generated
an apparent trend with temperature effect as described pre-
viously (22), although regression analysis did not conﬁrm
statistical signiﬁcance at the traditional level (p ¼ 0.08).
Cholesterol extraction further increased the hydrolysis rate of
the ionomycin-treated cells at all temperatures. The general
effect of cholesterol removal on hydrolysis was summarized by
pooling the data at all temperatures and comparing the effects
of ionomycin and MBCD by two-way analysis of variance
(Fig. 2 C). Ten percent of the variation in the data was attrib-
utable to ionomycin with very high statistical signiﬁcance (p,
0.0001). MBCD accounted for 26% of variation in initial rate
(p, 0.0001). The interaction between MBCD and ionomycin
accounted for 2.2% of variation in initial rate (p ¼ 0.03).
FIGURE 1 Effects of MBCD and ionomycin treatment
on the time course of membrane hydrolysis by sPLA2. (A)
Erythrocytes were treated with MBSS (curve a) or MBCD
(curve b). Samples were then washed and incubated with
ADIFAB and DMSO at 37C as explained in Materials and
Methods. The origin on the graph corresponds to the
addition of sPLA2. Fatty acid release is expressed in GP
units (i.e., representing the degree of change in ADIFAB
ﬂuorescence). Curves represent nonlinear regression ﬁts of
the data using an arbitrary function consisting of the sum of
two exponential functions. (B) The experiments of panel A
were repeated with ionomycin instead of DMSO.
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Fig. 3 illustrates the overall effect of cholesterol removal
on total product hydrolyzed (analyzed as for Fig. 2 C).
Cholesterol removal increased total product at all tempera-
tures regardless of ionomycin. One percent of the variation
was attributable to ionomycin (p ¼ 0.09). MBCD accounted
for 37% of variation (p, 0.0001). No signiﬁcant interaction
between MBCD and ionomycin was observed (p ¼ 0.95).
The assumption in all of these experiments is that the effect
of MBCD is conﬁned to the removal of cholesterol from the
cell membrane. One way to test that assumption is to load
MBCD with cholesterol before incubation with the erythro-
cytes. Presumably, preloading would interfere with the
ability of the agent to remove cell cholesterol while retaining
other potential artifactual effects. Fig. 4 demonstrates that
preloading MBCDwith cholesterol attenuated or removed its
effect on the initial rate of membrane hydrolysis, suggesting
that the results described above represent effects of choles-
terol depletion rather than direct artifacts of MBCD.
The consequences of cholesterol depletion on membrane
structure were assessed by two-photon ﬂuorescence micros-
copy using laurdan as a probe at multiple temperatures be-
tween 25C and 50C (Fig. 5). Laurdan is sensitive to the
presence and mobility of water molecules trapped within the
lipid bilayer (52) and has been shown to detect lipid order and
phases in the membrane (52,56). Comparison of the top
(control) and bottom (MBCD-treated) images of each panel
in Fig. 5 reveals three observations associated with MBCD
treatment. First, the average laurdan GP value was reduced
after cholesterol depletion. Second, the change in GP was
spread across the entire cell, although it appeared visually
that the largest changes occurred where the highest GP values
were previously observed. Third, the average cell diameter
was reduced after MBCD treatment as expected (46). The
experiments of Fig. 5 were repeated several times by ﬂuo-
rescence spectroscopy to obtain a more quantitative repre-
sentation of the effect of MBCD. The inﬂuences of both
temperature and MBCD were statistically signiﬁcant based
on a two-way analysis of variance. Temperature accounted
for 8% of the variation (p , 0.0001) displaying a trend
consistent with previous reports (22,29). MBCD treatment
lowered the average GP value by 0.14 units. The effect of
MBCD accounted for;33% of the variation in the data (p¼
0.02; n ¼ 5 (control) or 7 (MBCD)).
The relationship between laurdan GP and subsequent hy-
drolysis rates upon addition of sPLA2 are shown in Fig. 6.
Panel A shows hydrolysis of cells that have not received
ionomycin. The hydrolysis rate was relatively insensitive to
lipid order except where the membrane was most disordered
(i.e., at laurdan GP , 0.05). Upon ionophore addition, the
relationship was altered substantially in that hydrolysis rates
were sensitive to membrane order throughout the full range
of laurdan GP values (panel B). In both cases, the overall
trends were statistically signiﬁcant (p , 0.0001).
Previous studies have suggested that the enhanced hy-
drolysis promoted by ionophore treatment relates to addi-
tional changes in membrane order created by the calcium
inﬂux (21,22,53,57). These additional changes were identi-
ﬁed as local increases in membrane order focused in domains
visible mostly in the central region of the erythrocyte disk.
The boundaries around these nascent domains were hypoth-
esized to be the regions of the membrane most vulnerable to
attack by sPLA2 (22,23). If these changes in membrane order
FIGURE 2 Effects of temperature on rate
of hydrolysis by sPLA2. The experiments of
Fig. 1 A (DMSO; shown in panel A) and B
(ionomycin; shown in panel B) were repeated at
the multiple temperatures indicated for control
cells (squares, solid lines) and for cells treated
with MBCD (triangles, dashed lines). The
initial rate of hydrolysis was estimated by
nonlinear regression as described in Materials
and Methods. (C) Data from all temperatures
were pooled and analyzed by two-way analysis
of variance to assess the contributions of
ionomycin (9.8% of variation, p , 0.0001),
MBCD (26% of variation, p , 0.0001), and
interaction between the two (2.2% of variation,
p ¼ 0.03), n ¼ 5–7 per temperature.
FIGURE 3 Effect of MBCD treatment on total hydrolysis by sPLA2. The
total amount of hydrolysis was evaluated for the experiments of Fig. 2 at 500 s
(represented by ADIFAB GP) as explained in Materials and Methods. Data
were analyzed by two-way analysis of variance to calculate the contribution of
ionomycin (1.4% of variation, p ¼ 0.09), MBCD (37% of variation, p ,
0.0001), and interaction between the two (0% of variation, p ¼ 0.95), n ¼
32–35.
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caused by calcium loading are truly the physical event re-
sponsible for enhanced susceptibility to hydrolysis, they
should be exaggerated by MBCD treatment.
To test this prediction, two-photon images of the effect of
ionomycin treatment on laurdan ﬂuorescence were obtained
without or with prior treatment with MBCD at 25C, 37C,
and 45C. The results were visualized by comparing histo-
grams of GP values obtained by pooling data from several
images (Fig. 7). Separate histograms are shown for the central
(lower GP) region of the cells and for the perimeter. In control
cells, ionomycin treatment caused an elevation of the average
GP value and a narrowing of the distribution. The effect was
generally more prominent in the central region of the cell; the
perimeter was less affected. Cholesterol depletion as reported
in Figs. 5 and 6 decreased the averageGP value, and similar to
ionomycin, narrowed the distribution of GP values. In cho-
lesterol-depleted cells, ionomycin treatment had a minimal
effect on laurdan ﬂuorescence at 25C (control and MBCD
curves are essentially superimposable). At 37Cand 45C, the
observations were similar to those in control cells, but the
effect of ionomycin was generally weaker. The bottom panel
of Fig. 7 summarizes the average change in laurdan GP upon
calcium loading observed in multiple samples (combining
data from both microscopy and ﬂuorescence spectroscopy).
The overall effects observed in the two-photon experiments
were reproducible. Two-way analysis of variance indicated
that the effect of cholesterol depletion was more signiﬁcant
(p ¼ 0.04) than the effect of temperature on the action of
ionomycin (p ¼ 0.11 interaction insigniﬁcant: p ¼ 0.57, n ¼
12 in each group).
DISCUSSION
This study is, to our knowledge, the ﬁrst attempt to relate
sPLA2 activity, membrane cholesterol content, and mem-
brane order in a living cell. Importantly, it has created a new
opportunity to apply biophysical principles from artiﬁcial
bilayers to cell membranes. Speciﬁcally, the data provide
three insights. First, the summary in Fig. 6 demonstrates a
strong relationship between apparentmembrane order (laurdan
GP) and the activity of sPLA2, especially for cells made
susceptible by calcium inﬂux. This relationship was implied
previously in temperature studies (22) but is now greatly
strengthened by the data from cells treated with MBCD.
Second, the data support the hypothesis that cholesterol in-
hibits hydrolysis of biological membranes as it often does in
FIGURE 4 Preloading MBCD with cholesterol removes its effect on
membrane hydrolysis. Erythrocytes were incubated with MBSS (as a
control), MBCD, or preloaded MBCD according to Materials and Methods.
The initial hydrolysis rate upon addition of sPLA2 was assessed as in Fig. 2.
Data were analyzed by one-way analysis of variance (repeated measures)
with a posttest (Bonferroni). The MBCD-treated samples were distinguish-
able from both the control and preloaded MBCD-treated groups (p, 0.01).
There was no signiﬁcant difference between the control and the preloaded
MBCD treatment (p . 0.05), n ¼ 7.
FIGURE 5 Effects of MBCD treatment on
laurdan GP at multiple temperatures. Two-
photon images of erythrocytes were gathered
at 25C, 30C, 35C, 40C, 45C, and 50C as
explained in Materials and Methods. Control
cells are shown on the top half of each panel
with MBCD-treated cells below. Laurdan GP
values range from 0.50 (blue) to 0.75 (red).
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artiﬁcial bilayers. Third, the data of Fig. 7 help resolve
questions regarding the role of membrane order in the
mechanism by which cells become susceptible to hydrolysis
upon perturbation with elevated intracellular calcium.
Membrane order and sPLA2 activity
Several previous studies have addressed relationships be-
tween sPLA2 activity and the physical properties of artiﬁcial
membranes (6–9,12–15,58–62). These relationships can be
segregated into two categories. One category relates to
membrane phase properties like lipid order and ﬂuidity. In
general, increases in membrane ﬂuidity and disorder promote
hydrolytic activity (4,5,7,15,63). The other category com-
prises speciﬁc perturbations to membrane structure that im-
prove interactions of sPLA2 with the membrane surface and/
or access of bilayer substrate to the enzyme’s active site.
Examples of these perturbations include increased surface
curvature, negative surface charge, and the presence of bilayer
contaminants that weaken phospholipid/neighbor interac-
tions in the membrane (6–10,12–14,58–60). Even though
these two categories are not entirely independent in terms of
their mutual effects on membrane behavior and hydrolytic
activity, we have classiﬁed them in this way because they
appear to modulate the enzyme by separate means (7,8,
14,64). For example, regardless of how ﬂuid or disordered the
membrane is, hydrolysis can still be greatly accelerated by
inclusion of one of these perturbants (5–7). Moreover, the
perturbants appear always to affect sPLA2 activity to a larger
extent than do membrane order or ﬂuidity (5–7).
The data in this report strongly support the conclusion that
the action of sPLA2 on erythrocytes involves the same two
categories of membrane behavior. Previous studies have
provided ample evidence that calcium loading with ion-
omycin increases sPLA2 activity in amanner analogous to the
perturbants described above for model membranes (21,
23,53). An initial study in which temperature was varied
suggested that the effects of lipid order and/or ﬂuidity char-
acterized in artiﬁcial bilayers also relate to erythrocyte
membranes (22). However, that study was restricted by the
fact that temperatures above 50Cwere not reasonable to use,
and membrane order could therefore not be reduced sufﬁ-
ciently to fully explore its impact in the biological membrane.
Consequently, it was concluded that membrane order impacts
the activity of sPLA2 onlywhen themembrane has beenmade
susceptible by ionophore treatment (22). As shown by the
solid symbols in Fig. 6, the same conclusion would have been
reached here if the data with MBCD treatment had not been
included. In fact, similar to what has been observed in artiﬁ-
cial membranes, the enzyme appeared exquisitely sensitive to
lipid order when the membrane was highly disordered, and
this dependence was different in the presence of an activating
perturbation (i.e., ionomycin).
Protective effect of cholesterol
The presence of cholesterol in artiﬁcial membranes has been
shown previously to modulate the activity of enzymes that act
at the lipid-aqueous interface. Examples include sPLA2 and
cholesterol oxidase (26,34). Presumably, such modulation
reﬂects changes in membrane physical properties provoked
by the sterol. In the case of sPLA2, membrane cholesterol
often reduces the activity of the enzyme (33,34,36), although
a few examples of stimulatory effects in artiﬁcial bilayers
under speciﬁc experimental conditions have been reported
(36,37). In part, the inhibition probably results from the or-
dering effect of cholesterol on bilayer phospholipids since
sPLA2 is so sensitive to lipid dynamics (8,12,59,61–63). An
excellent example of this phenomenon is the relationship
among cholesterol superlattices, membrane structure, and
sPLA2 function. At the critical sterol concentrations produc-
ing the superlattices, membrane order reaches a maximum,
and the activity of sPLA2 reaches a minimum (34,65). Inter-
estingly, not all interfacial enzymes are affected the sameway
as revealed by investigations with cholesterol oxidase, which
is activated when superlattices are present (26).
The data of Figs. 1 and 2 reveal that cholesterol may also
perform an inhibitory role in erythrocyte membranes. Inter-
estingly, both the rate (Fig. 2) and the amount (Fig. 3) of
hydrolysis were increased by removal of cholesterol. The
impact on hydrolysis rate may well be explained by the
FIGURE 6 Relationship between laurdan GP and hydrolysis rate. The
experiments of Fig. 5 were repeated with bulk samples by ﬂuorescence
spectroscopy (see Materials and Methods, 2.5 mM laurdan). The value of GP
was calculated from the data and matched by temperature to the hydrolysis
data from Fig. 2 for control samples (solid squares) and those treated with
MBCD (open squares). (A) Hydrolysis data originated from DMSO samples
in Fig. 2 A. (B) Hydrolysis data originated from ionomycin samples in Fig. 2 B.
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membrane ordering effect of cholesterol (Fig. 6). On the other
hand, the elevated amount of hydrolysis is not easily rational-
ized by appeal to studies on artiﬁcial bilayers. This unexpected
result suggests that the pool of phospholipids accessible to the
enzyme is less than the total population present in native
membranes. Previously, it was shown that neither alteration of
experimental temperature nor treatment with ionomycin al-
tered the size of that pool (23), and our results here are generally
consistent with that report. Apparently, cholesterol plays a role
in limiting that pool in erythrocytes, perhaps by forming lipid
domains resistant to hydrolysis. Regardless of mechanism, this
behavior of the sterol would presumably perform a protective
function for cells circulating among plasma sPLA2 molecules.
This observationmayalsoexplainwhy the extent (in addition to
the rate) of phospholipid hydrolysis by sPLA2 is so much
greater in lymphocytes than it is in erythrocytes (using the same
enzyme preparation (18,19,21)). Indeed, lymphocyte cell
membranes contain much lower levels of cholesterol than do
thoseof erythrocytes (;30%asopposed to;50%(38,40–42)).
One important caveat to this and other studies with cy-
clodextrins is that their speciﬁcity for cholesterol is not ab-
solute (reviewed in Zidovetzki and Levitan (66)). Additional
lipids such as sphingomyelin, glycosphingolipids, and glyc-
erophospholipids can also be extracted, especially with high
MBCD concentrations and lengthy incubations. Based on
previous measurements of relative phospholipid and cho-
lesterol depletion from human erythrocytes, the mild condi-
tions used here (1 mM MBCD, 30 min incubation) and the
high efﬁciency with which cholesterol was removed suggest
that no more than a few percent of phospholipids were ex-
tracted in our experiments (46,67). Furthermore, the control
experiment displayed in Fig. 4 and our efforts to quantify the
amount of cholesterol extracted support the idea that the ef-
fects studied here relate to cholesterol depletion. Neverthe-
less, we cannot exclude the possibility that additional lipids
occupying the same site as cholesterol on the dextrin have
been extracted and are relevant to the results reported here.
This consideration should always temper interpretations
using MBCD.
Does the perturbant act by changing
membrane order?
One area that has been somewhat controversial in compari-
sons among artiﬁcial membranes, lymphocytes, and eryth-
rocytes is the role of changes in membrane order induced by
perturbants that cause enhanced hydrolysis by sPLA2. In
artiﬁcial bilayers, the various perturbants that activate the
enzyme exert a diversity of effects on membrane order: some
increase the average order, some decrease it, and others have
no effect (8,64). In lymphocytes, treatment of the cells with
ionomycin to induce susceptibility to sPLA2 produces no
change in membrane lipid order (24). Thus, the initial ob-
servations of an increase in the number of ordered domains in
erythrocytes upon ionomycin treatment appeared unique to
that cell type. Now, the data of Fig. 7 provide clariﬁcation by
FIGURE 7 Effect on ionomycin treatment on
laurdan GP in control and MBCD-treated samples.
(Upper two rows of panels) Laurdan GP was
assessed from two-photon images as in Fig. 5 for
control and MBCD-treated samples before and
after addition of ionomycin. Histograms of the
central region and perimeter of the cells at 25C,
37C, and 45C were calculated from the images as
described in Materials and Methods. These histo-
grams were then ﬁt by nonlinear regression (arbitrary
function) and normalized. Control cells (MBSS-
treated) are represented in black and MBCD-treated
cells are represented in gray with the lighter, dashed
lines corresponding to cells after ionomycin treat-
ment. (Lower panel) The average change in laurdan
GP after ionomycin treatment at 25C, 37C, and
45C is shown for both control and MBCD-treated
cells. Data from images (250 nM laurdan, n ¼ 3 in
each group) and bulk samples using ﬂuorescence
spectroscopy (250–460 nM laurdan; n ¼ 9) have
been pooled. Two-way analysis of variance showed
the effects of cholesterol depletion (5.8% of varia-
tion, p ¼ 0.04), temperature (5.9% of variation, p ¼
0.11), and interaction between the two (1.5% of
variation, p ¼ 0.57).
3090 Heiner et al.
Biophysical Journal 94(8) 3084–3093
suggesting the absence of a correlation between effects of
ionomycin on membrane order and on hydrolysis. For ex-
ample, removal of cholesterol from the cell membrane below
30C created a scenario in which the ability of ionomycin to
induce susceptibility was great (Fig. 2) but the change in
laurdanGP associated with the ionophore was absent (Fig. 7).
Thus, we conclude that perturbants do not induce membrane
susceptibility to sPLA2 by changing membrane order. This
interpretation appears to apply broadly to artiﬁcial bilayers
and to all cell types tested thus far. Instead, the hypothesis
proposed from model membranes that perturbants promote
hydrolysis by increasing negative surface charge and/or by
reducing the strength of interactions among neighboring
phospholipids appears to be a superior explanation (8,23,24).
CONCLUSIONS
In summary, two conclusions can be drawn from these stud-
ies. First, biophysical observations of the behavior of sPLA2
in model membranes apply also to biological membranes,
notwithstanding the complexity of that behavior. This con-
clusion appears to be true both in terms of the effects of lipid
order/ﬂuidity on the activity of the enzyme as well as on the
ability of speciﬁc bilayer perturbations (e.g., fatty acid or lyso-
phospholipid in model membranes, ionophore treatment on
cell membranes) to further render the membrane susceptible
to hydrolytic attack. Second, the high concentration of cho-
lesterol in erythrocyte membranes has been suggested to play
an important protective role for the cells by conferring me-
chanical stability to the cell membrane (68). We now show
that the same may be true physiologically for protecting cells
from attack by hydrolytic enzymes present in the blood. This
idea makes sense because nucleated cells possess other
mechanisms such as endocytosis that appear to confer pro-
tection against hydrolytic enzymes by sequestering and
clearing them from the cell surface (69). Erythrocytes, how-
ever, are incapable of such processes and therefore must rely
on the biophysical properties of their membranes as their sole
protection from these enzymes.
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